Home Banking & Finance Yonkers biotech ContraFect announces public offering of common stock

Yonkers biotech ContraFect announces public offering of common stock

SHARE

The company expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock sold in the offering.

This content is for Westfair Online members only. Please to view this content. Become a member by Registering Here.
Print Friendly, PDF & Email